[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Endocrinology](https://durgical.com/en/endocrinology/) › [Diabetes](https://durgical.com/en/endocrinology/areas/diabetes/) › Glycaemic targets, HbA1c and continuous glucose monitoring

# Glycaemic targets, HbA1c and continuous glucose monitoring

- Follow-up and treatment

There is no single «good sugar» for everyone. A fit 40-year-old and a frail 85-year-old need different targets, and a sensor shows what [HbA1c](https://durgical.com/en/biochemistry/topics/glycated-haemoglobin/) hides.

Updated Nov 16, 2026

## Key points

- Most adults: HbA1c below 7%; frail or short [life expectancy](https://durgical.com/en/epidemiology/life-expectancy/): below 8% or avoid symptoms.
- HbA1c 7% ≈ average [glucose](https://durgical.com/en/biochemistry/molecules/glucose/) 154 mg/dL.
- CGM: time in range 70–180 mg/dL above 70%; below 70 mg/dL under 4%; below 54 mg/dL under 1%.
- Look at time below range first.
- HbA1c every three months until at target, then every six.

On this page

- The basics Key points
- What it is
- How to think about it
- What to know
- Choosing the HbA1c target
- Common traps
- Elsewhere in DurgiPedia

- Clinical In the clinic

- Treatment Next step / Initial management

- Study Test yourself

- Connections Connections

## What it is

HbA1c reflects the average glucose of the past two to three months. For most non-pregnant adults the target is below 7% (53 mmol/mol); a lower target (below 6.5%) suits some young patients if it can be reached without [hypoglycaemia](https://durgical.com/en/conditions/hypoglycaemia/), and a higher one (below 8%) suits people with limited life expectancy, [frailty](https://durgical.com/en/conditions/frailty-syndrome/), advanced complications or a history of severe hypoglycaemia. Day-to-day control is checked by [capillary glucose](https://durgical.com/en/nursing/capillary-blood-glucose-testing/) (usual targets before meals 80–130 mg/dL and below 180 mg/dL one to two hours after eating) or by continuous glucose monitoring (CGM), which measures interstitial glucose every few minutes. CGM is summarised as time in range (70–180 mg/dL; target more than 70% of the day), time below range (below 70 mg/dL less than 4%, below 54 mg/dL less than 1%) and time above range, and it is recommended for everyone on insulin.

## How to think about it

HbA1c is the average of a whole season's weather; CGM is the hour-by-hour forecast. Two patients with the same 7% can have very different days: one steady, the other swinging between dangerous lows and highs. The average tells you whether to worry about complications in years; time below range tells you whether to worry about tonight.

## What to know

- Targets are individual: younger, healthy, short duration, no hypoglycaemia → lower target; frail, short life expectancy, severe hypoglycaemia, advanced complications → higher target.
- Older adults: healthy with few illnesses, below 7.0–7.5%; complex or intermediate health, below 8.0%; very complex or poor health, avoid hypoglycaemia and symptomatic hyperglycaemia rather than aiming at a number.
- Pregnancy: tighter targets (below 6% if reachable without hypoglycaemia, otherwise below 7%), because the fetus is exposed to every high.
- Children and adolescents: below 7% for most, with CGM metrics as for adults.
- An HbA1c of 7% corresponds to an average glucose of about 154 mg/dL (8.6 mmol/L).
- CGM targets for most adults: time in range above 70%, time below 70 mg/dL under 4%, below 54 mg/dL under 1%, above 180 mg/dL under 25%; for older or high-risk adults, time in range above 50% and time below 70 mg/dL under 1%.
- Glucose variability (coefficient of variation) at or below 36% marks stable control.
- The glucose management indicator (GMI) is an HbA1c estimated from CGM; a gap between GMI and laboratory HbA1c suggests a red-cell or haemoglobin problem.
- HbA1c is unreliable in anaemia, haemoglobin variants, recent transfusion or bleeding, pregnancy and advanced kidney disease: use glucose or CGM instead.
- Sensor readings lag blood glucose by several minutes, most when glucose changes fast; confirm with a fingerstick when symptoms and the sensor disagree.

## Choosing the HbA1c target

| Patient | Usual HbA1c target | Main concern |
| --- | --- | --- |
| Most non-pregnant adults | Below 7% | Prevent small-vessel complications |
| Young, healthy, short duration, no hypoglycaemia | Below 6.5% if safe | Long life ahead to accumulate damage |
| Healthy older adult | Below 7.0–7.5% | Balance benefit and hypoglycaemia |
| Frail, many illnesses, short life expectancy, severe hypoglycaemia | Below 8%, or avoid symptoms | Hypoglycaemia, falls, burden of treatment |
| Pregnancy | Below 6% if safe, otherwise below 7% | Fetal exposure to hyperglycaemia |

## In the clinic

- A falling HbA1c with new night-time confusion in an older patient is not a success: look for hypoglycaemia with CGM or night checks.
- A high HbA1c with normal fingerstick readings suggests the patient tests only at good moments, a meter problem, or high readings after meals that are never checked.
- People with [type 2 diabetes](https://durgical.com/en/general-pathology/type-2-diabetes/) on non-insulin drugs that do not cause hypoglycaemia rarely need daily fingersticks; testing is useful when starting or changing treatment, during illness, or to learn food effects.

## Next step / Initial management

- HbA1c every three months when not at target or after a change in treatment, and at least twice a year when stable.
- Agree an individual HbA1c target with each patient and write it in the record; review it as health changes.
- Offer CGM to everyone on insulin; review the ambulatory glucose profile at each visit, looking first at time below range, then time in range.
- When HbA1c and glucose readings disagree, check haemoglobin, kidney function and haemoglobin variants, and rely on glucose or CGM.
- Refer to endocrinology persistent time below range despite changes, hypoglycaemia unawareness, or pregnancy with diabetes.

## Common traps

- **Lower HbA1c is always better**: below an individual target, extra lowering mainly adds hypoglycaemia, and in frail or older patients that raises falls and deaths.
- **An HbA1c at target means control is fine**: the same average can hide frequent lows and highs, which only CGM or structured testing shows.
- **Sensor and fingerstick should match exactly**: interstitial glucose lags blood glucose, most when it is changing fast after meals or exercise.
- **HbA1c works the same in everyone**: anaemia, haemoglobin variants, pregnancy and kidney failure shift it independently of glucose.
- **Time in range above 70% is the target for every adult**: for older and high-risk adults the priority is time below range, so a lower time in range is accepted.

## Test yourself

Think of the answer, then tap the question to see it.

## An 84-year-old with dementia on insulin has an HbA1c of 6.4% and recent falls. What do you do with the target?

Relax it: for very complex health the goal is avoiding hypoglycaemia and symptoms, not a low number. Simplify treatment and check for lows.

## Two patients have an HbA1c of 7.2%. One has a time in range of 80%, the other 45% with 8% below range. Who needs urgent change?

The second: the same average hides frequent highs and dangerous lows. Time below range above 4% needs treatment changed first to prevent severe hypoglycaemia.

## A patient's CGM indicator (GMI) is 7.8% but the laboratory HbA1c is 6.2%. What might explain it?

A shortened red-cell lifespan (haemolysis, bleeding, kidney disease with erythropoietin) or a haemoglobin variant falsely lowering HbA1c.

[Add to my cards (3)](https://durgical.app/estudiar/?add=/en/endocrinology/glycaemic-targets-hba1c-and-continuous-glucose-monitoring/)

## Elsewhere in DurgiPedia

- [Physiology of diabetes and ketoacidosis](https://durgical.com/en/physiology/physiology-of-diabetes-and-ketoacidosis/)
- [Diabetes in pregnancy: screening, targets and timing of birth](https://durgical.com/en/obstetrics-gynaecology/diabetes-in-pregnancy-screening-targets-and-timing-of-birth/)
- [Diabetes self-management teaching before discharge: monitoring, food, activity and sick-day rules](https://durgical.com/en/nursing/diabetes-self-management-teaching-before-discharge-monitoring-food-activity-and/)

## Connections

## Related 5

- [Type 2 diabetes treatment: choosing drugs by the patient, not only by glucose](https://durgical.com/en/endocrinology/type-2-diabetes-treatment-choosing-drugs-by-the-patient-not-only-by-glucose/)
- [Insulin: basal, mealtime and correction, in principle](https://durgical.com/en/endocrinology/insulin-basal-mealtime-and-correction-in-principle/)
- [Living with type 1 diabetes: education, sick days and technology](https://durgical.com/en/endocrinology/living-with-type-1-diabetes-education-sick-days-and-technology/)
- [Hypoglycaemia: the Whipple triad, insulin and C-peptide](https://durgical.com/en/endocrinology/hypoglycaemia-the-whipple-triad-insulin-and-c-peptide/)
- [Diagnosing diabetes and telling the types apart](https://durgical.com/en/endocrinology/diagnosing-diabetes-and-telling-the-types-apart/)

## Related conditions 4

- [Type 1 diabetes mellitus](https://durgical.com/en/conditions/type-1-diabetes-mellitus/)
- [Type 2 diabetes mellitus](https://durgical.com/en/conditions/type-2-diabetes-mellitus/)
- [Hypoglycaemia (including insulin-induced)](https://durgical.com/en/conditions/hypoglycaemia/)
- [Gestational diabetes mellitus](https://durgical.com/en/conditions/gestational-diabetes-mellitus/)

## In Pharmacology 3

- [Insulins](https://durgical.com/en/pharmacology/classes/insulins/)
- [Sulfonylureas](https://durgical.com/en/pharmacology/classes/sulfonylureas/)
- [Metformin](https://durgical.com/en/pharmacology/metformin/)

[← All of endocrinology](https://durgical.com/en/endocrinology/)

Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.

Sources: [Hemoglobin A1C](https://www.ncbi.nlm.nih.gov/books/NBK549816/) (StatPearls (NCBI Bookshelf), 2025); [Type 2 Diabetes](https://www.ncbi.nlm.nih.gov/books/NBK513253/) (StatPearls (NCBI Bookshelf), 2023); [Type 1 Diabetes](https://www.ncbi.nlm.nih.gov/books/NBK507713/) (StatPearls (NCBI Bookshelf), 2024); [Hypoglycemia](https://www.ncbi.nlm.nih.gov/books/NBK534841/) (StatPearls (NCBI Bookshelf), 2022).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/endocrinology/glycaemic-targets-hba1c-and-continuous-glucose-monitoring/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/endocrinology/glycaemic-targets-hba1c-and-continuous-glucose-monitoring/
